SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2986PCYC >> Amazingly, he [Duggan] actually takes no salary and I think no opIRWIN JAMES FRANKEL-11/5/2012
2985At least there is this: Our CEO and Chairman, Robert W. Duggan, has advised us rkrw-11/5/2012
2984Thanks Tuck. You must be right about the stock sales, I know mm wasn't on mfred hayes-11/5/2012
2983PR upfront states that insiders may be selling some stock when the window opens tuck-11/5/2012
2982Pcyc is down about 1/3 from where it was awhile ago (from ~ 66 to 50 or so). I rfred hayes-11/5/2012
2981PCYC -15% on 3 x average daily volume so fartnsaf-11/5/2012
2980Optimer (OPTR) off 17% after hours after reporting earnings. This could be a fatuck-11/1/2012
2979Pain Therapeutics & DuRect (DRRX) both off ~33% after Pfizer, on its earnintuck-11/1/2012
2978$VVUS Weight-Loss Drug's Failing Math --> http://t.co/DJNStqO9 And paid2MAR$-11/1/2012
2977AEGR just topping out some , or at a pause but here's some good DD seekinga2MAR$-11/1/2012
2976MRNA down only 3% today but watch out: siliconinvestor.comDewDiligence_on_SI-10/31/2012
2975CNBC reporting that JP Morgan indicated the IMS data show sales slowing.IRWIN JAMES FRANKEL-10/31/2012
2974Looks like talk of missing estimates of sales may be the cause: thestreet.com IRWIN JAMES FRANKEL-10/31/2012
2973Probably scripts data like this guy noted "Two drug-tracking companies, IMidos-10/31/2012
2972VVUS off over 12% No reason I can see - they did announce earnings release for IRWIN JAMES FRANKEL-10/31/2012
2971Immunogen (IMGN), which has run up lately as possible FDA approval of T-DM1 drawtuck-10/26/2012
2970Wo! Sold back to bone pile when it went nuts, hadn't noticed it today. Thascaram(o)uche-10/25/2012
2969XNPT -13%IRWIN JAMES FRANKEL-10/25/2012
2968Depends on the cancer. Three different types were referenced in the briefing dotuck-10/17/2012
2967Wouldn't the possibility of reducing life expectancy for the target populatiIan@SI-10/16/2012
2966Isis (ISIS) of 21% after a run up into this imminent AC meeting for Mipomersen. tuck-10/16/2012
2965XNPT clipped 11% on PJ downgrade to hold, PT 12.IRWIN JAMES FRANKEL-10/12/2012
2964Aeterna Zentaris (AEZS), which had reverse split itself out of penny stock statutuck-10/12/2012
2963ARQL down over 60% on 3million shares pre-market. due to discontinuation of Mapgo-neil-10/2/2012
2962So much for yesterday's gain... Peregrine Pharma (PPHM 1.11, -0.55) fell 33Ian@SI-9/27/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News